{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:35:20Z","timestamp":1707525320899},"reference-count":6,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,10,9]]},"DOI":"10.7759\/cureus.46757","type":"journal-article","created":{"date-parts":[[2023,10,10]],"date-time":"2023-10-10T00:20:38Z","timestamp":1696897238000},"source":"Crossref","is-referenced-by-count":0,"title":["Devastating Worsening Renal Function Following the Initiation of Sacubitril\/Valsartan: Falling Between Two Stools"],"prefix":"10.7759","author":[{"given":"Akinori","family":"Sairaku","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukiko","family":"Nakano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1409077","article-title":"Angiotensin-neprilysin inhibition versus enalapril in heart failure","volume":"371","author":"McMurray JJ","year":"2014","unstructured":"McMurray JJ, Packer M, Desai AS, et al.. Angiotensin-neprilysin inhibition versus enalapril in heart failure. N Engl J Med. 2014, 371:993-1004. 10.1056\/NEJMoa1409077","journal-title":"N Engl J Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(09)61966-8","article-title":"Blood-pressure reduction with LCZ696, a novel dual-acting inhibitor of the angiotensin II receptor and neprilysin: a randomised, double-blind, placebo-controlled, active comparator study","volume":"375","author":"Ruilope LM","year":"2010","unstructured":"Ruilope LM, Dukat A, B\u00f6hm M, Lacourci\u00e8re Y, Gong J, Lefkowitz MP. Blood-pressure reduction with LCZ696, a novel dual-acting inhibitor of the angiotensin II receptor and neprilysin: a randomised, double-blind, placebo-controlled, active comparator study. Lancet. 2010, 375:1255-66. 10.1016\/S0140-6736(09)61966-8","journal-title":"Lancet"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2012.01.077","article-title":"Cardiorenal syndrome type 1: pathophysiological crosstalk leading to combined heart and kidney dysfunction in the setting of acutely decompensated heart failure","volume":"60","author":"Ronco C","year":"2012","unstructured":"Ronco C, Cicoira M, McCullough PA. Cardiorenal syndrome type 1: pathophysiological crosstalk leading to combined heart and kidney dysfunction in the setting of acutely decompensated heart failure. J Am Coll Cardiol. 2012, 60:1031-42. 10.1016\/j.jacc.2012.01.077","journal-title":"J Am Coll Cardiol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1002\/ehf2.13002","article-title":"Effect of sacubitril\/valsartan on renal function: a systematic review and meta-analysis of randomized controlled trials","volume":"7","author":"Spannella F","year":"2020","unstructured":"Spannella F, Giulietti F, Filipponi A, Sarzani R. Effect of sacubitril\/valsartan on renal function: a systematic review and meta-analysis of randomized controlled trials. ESC Heart Fail. 2020, 7:3487-96. 10.1002\/ehf2.13002","journal-title":"ESC Heart Fail"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.111.963413","article-title":"Is worsening renal function an ominous prognostic sign in patients with acute heart failure? The role of congestion and its interaction with renal function","volume":"5","author":"Metra M","year":"2012","unstructured":"Metra M, Davison B, Bettari L, et al.. Is worsening renal function an ominous prognostic sign in patients with acute heart failure? The role of congestion and its interaction with renal function. Circ Heart Fail. 2012, 5:54-62. 10.1161\/CIRCHEARTFAILURE.111.963413","journal-title":"Circ Heart Fail"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-016-2072-7","article-title":"Effect of renal function on the pharmacokinetics of LCZ696 (sacubitril\/valsartan), an angiotensin receptor neprilysin inhibitor","volume":"72","author":"Ayalasomayajula SP","year":"2016","unstructured":"Ayalasomayajula SP, Langenickel TH, Jordaan P, et al.. Effect of renal function on the pharmacokinetics of LCZ696 (sacubitril\/valsartan), an angiotensin receptor neprilysin inhibitor. Eur J Clin Pharmacol. 2016, 72:1065-73. 10.1007\/s00228-016-2072-7","journal-title":"Eur J Clin Pharmacol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/183466-devastating-worsening-renal-function-following-the-initiation-of-sacubitrilvalsartan-falling-between-two-stools","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:10:42Z","timestamp":1707509442000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/183466-devastating-worsening-renal-function-following-the-initiation-of-sacubitrilvalsartan-falling-between-two-stools"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,9]]},"references-count":6,"URL":"https:\/\/doi.org\/10.7759\/cureus.46757","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10,9]]}}}